Stay updated on Zephyrus I Clinical Trial
Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.

Latest updates to the Zephyrus I Clinical Trial page
- Check6 days agoNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe update adds a 'Show glossary' option and adjusts metadata to 'Last Update Submitted that Met QC Criteria,' updates the 'No FEAR Act Data' label, and changes the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedKyntra Bio has been added as sponsor and FibroGen removed, and the page revision has been updated to v3.3.4.SummaryDifference0.1%

- Check50 days agoChange DetectedThe Locations section has been expanded with many new study sites across the United States, Argentina, Australia, and China, and the revision tag updated to v3.3.3.SummaryDifference3%

- Check71 days agoChange DetectedObserved a minor page metadata update: Revision: v3.3.2 added and Revision: v3.3.1 removed; no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange Detected- Added automatic PubMed publications note and updated the page revision to v3.3.1.SummaryDifference0.0%

- Check85 days agoChange DetectedRemoved the government funding lapse notice from the page, which previously described potential delays and operating status; the page now presents the trial details without that disclaimer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Zephyrus I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.